Conference Coverage
Advantages to Continuing Pemetrexed as Maintenance Therapy in the KEYNOTE-189 Regimen
Corey Langer, MD
05/14/2024
At the Great Debates and Updates in Lung Cancer Meeting in New York, New York, Corey Langer, MD, Abramson Cancer Center, Philadelphia, Pennsylvania, argued that continuing pemetrexed maintenance therapy is advantageous for patients treated with the KEYNOTE-189 regimen.
Source:
Langer C. Debate: Should Pemetrexed Be Continued in KEYNOTE-189? Presented at Great Debates & Updates in Lung Cancer; April 27-28, 2024; New York, NY.